Keyplants and capabilities include full in-house Design and Fabrication as well as subject matter expertise in biologics, aseptic filling, containment and manufacturing of APIs and oral solids.
The largest Life Science facility ever built in Europe using modular off-side manufacturing.
KeyPlants is responsible for the complete project, including detail design, ground works and construction on-site, installation of all equipment, as well as qualificaion. The floor area of the new facility is around 13000 m2 and will be located in direct connection to Galderma’s current Uppsala plant.
Facility extension with a modular building to increase vaccine manufacturing capacity. A 4-story extension to an existing building with integrated cold rooms and buffer preparation process areas. Facade and roof installed on site to match the adjacent building.
Turnkey delivery of a modular aseptic filling facility to Insitute Pastur de Dakar(IPD) in Senegal, Africa, The first target will be COVID-19 vaccine production, with the flexibility to adapt to future needs.
Turnkey delivery of two modular facilities for bulk manufacturing filling. Based on KeyPlant’s design platforms MBSTM and MASTM. Outdoor integrated process buildings. Bacterial fermentation with UF and chromatography purification. Liquid and lyo vials, powder-filling in vials and two-chamber syringes.
Turnkey delivery of a modular Fill Finish facility based on KeyPlants design platform Modular Aseptic Solutions(MASM) from concept design to handover. Indoor “Box-in-Box” integrated process buildings. Combi-filler for vials, syringes and cartridges. Pre-sterlized RTU containers in nests. Formulation in stainless steel tanks and disposables.